Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey
Overview
Affiliations
Objective: To investigate the prevalence of overweight and obesity, as well as the association between body mass index (BMI) and disease activity in patients with axial spondyloarthritis (axSpA).
Methods: Norwegian axSpA patients from the European Map of Axial Spondyloarthritis (EMAS) survey were included in this analysis. Sociodemographic, anthropomorphic, and disease-related variables (HLA-B27, comorbidities, BASDAI, and self-reported spinal stiffness) were reported. Patients were categorized into under/normal weight (BMI < 25 kg/m), overweight (BMI ≥ 25 to < 30 kg/m), and obese (≥ 30 kg/m).
Results: Of the 509 participants in the EMAS survey, 35% were categorized as under/normal weight, 39% overweight, and 26% obese. Compared to under/normal-weight patients, overweight patients had significantly higher degree of spinal stiffness (mean (SD) 7.91 ± 2.02 vs 7.48 (2.15) and number of comorbidities (2.45 ± 2.11, vs 1.94), both p < 0.001. Obese patients had significantly higher disease activity (BASDAI mean (SD) 5.87 ± 1.78 vs 4.99 ± 2.08, p < 0.001), degree of spinal stiffness (8.18 ± 2.03 vs 7.48 ± 2.15, p = 0.006), and number of comorbidities (3.43 ± 2.43 vs 1.94. ± .38, p < 0.001) than under/normal weight patients. After adjusting for gender and age, obesity proved to be independently associated with disease activity.
Conclusion: Obesity was associated with higher reported BASDAI score, and being overweight or obese was associated with a higher degree of spinal stiffness and number of comorbidities compared to under/normal weight respondents. The results highlight the serious impact of obesity on health status, and obesity should therefore be considered as a modifiable risk factor for disease activity within the disease management of axSpA.
Corrado A, Guadagni I, Picarelli G, Variola A Immun Inflamm Dis. 2025; 13(1):e70080.
PMID: 39760506 PMC: 11702394. DOI: 10.1002/iid3.70080.
Queiro R, Alonso-Castro S, Brana I, Loredo M, Pardo E, Burger S J Clin Med. 2024; 13(22).
PMID: 39597945 PMC: 11594675. DOI: 10.3390/jcm13226801.
Makan K, Garrido-Cumbrera M, Du Toit R, Correa-Fernandez J, van Dam M, Tikly M Clin Rheumatol. 2024; 43(11):3335-3343.
PMID: 39333345 PMC: 11489170. DOI: 10.1007/s10067-024-07151-8.
Garrido-Cumbrera M, Poddubnyy D, Sommerfleck F, Bundy C, Makri S, Correa-Fernandez J RMD Open. 2024; 10(2).
PMID: 38851236 PMC: 11163687. DOI: 10.1136/rmdopen-2023-003504.
Biomechanics in the onset and severity of spondyloarthritis: a force to be reckoned with.
Iyer P, Hwang M, Ridley L, Weisman M RMD Open. 2023; 9(4).
PMID: 37949613 PMC: 10649803. DOI: 10.1136/rmdopen-2023-003372.